These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 12818165)

  • 1. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
    Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
    Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7S1, a novel B7 family member that negatively regulates T cell activation.
    Prasad DV; Richards S; Mai XM; Dong C
    Immunity; 2003 Jun; 18(6):863-73. PubMed ID: 12818166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.
    Choi IH; Zhu G; Sica GL; Strome SE; Cheville JC; Lau JS; Zhu Y; Flies DB; Tamada K; Chen L
    J Immunol; 2003 Nov; 171(9):4650-4. PubMed ID: 14568939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity.
    Zhu G; Augustine MM; Azuma T; Luo L; Yao S; Anand S; Rietz AC; Huang J; Xu H; Flies AS; Flies SJ; Tamada K; Colonna M; van Deursen JM; Chen L
    Blood; 2009 Feb; 113(8):1759-67. PubMed ID: 19109567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine tuning the immune response through B7-H3 and B7-H4.
    Yi KH; Chen L
    Immunol Rev; 2009 May; 229(1):145-51. PubMed ID: 19426220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unstable B7-H4 cell surface expression and T-cell redirection as a means of cancer therapy.
    Iizuka A; Kondou R; Nonomura C; Ashizawa T; Ohshima K; Kusuhara M; Isaka M; Ohde Y; Yamaguchi K; Akiyama Y
    Oncol Rep; 2016 Nov; 36(5):2625-2632. PubMed ID: 27632942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
    MacGregor HL; Ohashi PS
    Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H4 expression promotes tumorigenesis in ovarian cancer.
    Cheng L; Jiang J; Gao R; Wei S; Nan F; Li S; Kong B
    Int J Gynecol Cancer; 2009 Dec; 19(9):1481-6. PubMed ID: 19955922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma.
    Kryczek I; Zou L; Rodriguez P; Zhu G; Wei S; Mottram P; Brumlik M; Cheng P; Curiel T; Myers L; Lackner A; Alvarez X; Ochoa A; Chen L; Zou W
    J Exp Med; 2006 Apr; 203(4):871-81. PubMed ID: 16606666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Could B7-H4 serve as a target to activate anti-cancer immunity?
    Wang L; Heng X; Lu Y; Cai Z; Yi Q; Che F
    Int Immunopharmacol; 2016 Sep; 38():97-103. PubMed ID: 27258187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a novel monoclonal antibody to B7-H4: characterization and biological activity.
    Qian Y; Shen L; Xu C; Wu Z; Brockmeyer NH; Altmeyer P; Wu N; Yao HP
    Eur J Med Res; 2011 Jul; 16(7):295-302. PubMed ID: 21813370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle arrest induced by engagement of B7-H4 on Epstein-Barr virus-positive B-cell lymphoma cell lines.
    Park GB; Song H; Kim YS; Sung M; Ryu JW; Lee HK; Cho DH; Kim D; Lee WJ; Hur DY
    Immunology; 2009 Nov; 128(3):360-8. PubMed ID: 20067536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.
    Lu B; Chen L; Liu L; Zhu Y; Wu C; Jiang J; Zhang X
    Immunol Res; 2011 Aug; 50(2-3):269-75. PubMed ID: 21717068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced T cell immunity by B7-H4 downregulation in nonsmall-cell lung cancer cell lines.
    Sun SQ; Jiang CG; Lin Y; Jin YL; Huang PL
    J Int Med Res; 2012; 40(2):497-506. PubMed ID: 22613410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costimulatory molecule B7-H4 promote tumor progression and cell proliferation through translocating into nucleus.
    Zhang L; Wu H; Lu D; Li G; Sun C; Song H; Li J; Zhai T; Huang L; Hou C; Wang W; Zhou B; Chen S; Lu B; Zhang X
    Oncogene; 2013 Nov; 32(46):5347-58. PubMed ID: 23318460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H4, a promising target for immunotherapy.
    Wang JY; Wang WP
    Cell Immunol; 2020 Jan; 347():104008. PubMed ID: 31733822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
    Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
    Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Construction and identification of recombinant adenoviral vector encoding B7-H4 gene].
    Yan PY; Yao HP; Qian Y; Gu LJ; Tao L; Zhang LH
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 37(5):499-505. PubMed ID: 18925719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.